Acne Journals

• Utilization of Topical Ruxolitinib in Dermatology This review summarizes the use of topical ruxolitinib, a JAK inhibitor, in various dermatological conditions including vitiligo, alopecia areata, atopic dermatitis, psoriasis, and more.
  Skin Therapy Letter, September 04, 2023
• Myoinositol With Metformin vs Metformin Monotherapy in PCOS An RCT looked at the effects of metformin alone or combined with myoinositol in the treatment of PCOS. How do they compare?
  Clinical Endocrinology, August 14, 2023
• Evolving Story of JAK Inhibitors for Treating Alopecia Areata Review the introduction of Janus kinase inhibitors and their application as the first-line therapeutic option for severe alopecia areata. What might be the future role of JAK inhibitors in this area?
  Skin Therapy Letter, August 03, 2023
• Testosterone for HSDD in Postmenopausal Women Review the use of transdermal testosterone for postmenopausal women with hypoactive sexual desire disorder.
  Menopause, July 20, 2023
• Mpox in Young Woman With No Epidemiologic Risk Factors An mpox diagnosis was confirmed in a young woman who presented with a facial rash with no known risk factors.
  Emerging Infectious Diseases, June 22, 2023
• Effects of Exercise and Diet on Hidradenitis Suppurativa How might exercise, weight loss, and dietary modifications be utilized as alternatives and/or adjuncts to treating hidradenitis suppurativa?
  American Journal of Clinical Dermatology, June 05, 2023
• Antibiotic Resistance in Dermatology: Combating Resistance It's crucial that dermatologists aim to combat antibiotic resistance, given the high use of antibiotics in dermatology. Review the appropriate use of antibiotics in common dermatoses in this paper.
  Skin Therapy Letter, June 01, 2023
• Pyoderma Gangrenosum in a Patient With Dubowitz Syndrome This case report describes the presentation of pyoderma gangrenosum in a patient with Dubowitz syndrome. Are these two conditions connected?
  Wounds, May 10, 2023
• Antibiotic Resistance in Dermatology: Mechanisms of Resistance This article presents a brief review of the use of antibiotics in dermatology, their mechanisms of action, and mechanisms by which antibiotic resistance develops.
  Skin Therapy Letter, May 01, 2023
• New Razor Technology Improves QoL in Pseudofolliculitis Barbae A novel razor technology designed specifically for men with pseudofolliculitis barbae was found to improve skin appearance and quality of life in men who wish to continue shaving.
  Cutis, March 08, 2023
• Acne Scars: An Update on Management Acne scars can negatively impact patients' quality of life. What is the latest evidence on effective treatment for various types of acne scarring?
  Skin Therapy Letter, March 01, 2023
• Dietary Triggers for Atopic Dermatitis in Children While food allergies are often suspected of being the cause of atopic dermatitis in children, true true food-triggered AD is surprisingly rare, as discussed in this paper.
  Cutis, March 01, 2023
• Selective TYK2 Inhibition in Chronic Plaque Psoriasis This articles focuses on oral deucravacitinib, a first-in-class selective tyrosine kinase 2 inhibitor for the treatment of moderate-to-severe chronic plaque psoriasis.
  Skin Therapy Letter, February 15, 2023
• Routine Testing in Healthy Young Patients Taking Isotretinoin Routine liver function, lipids and full blood count testing was originally recommended for patients taking isotretinoin. Is there evidence to support a benefit in healthy young people?
  The British Journal of Dermatology, December 20, 2022
• COVID-19 and Diabetes Risk: Translating Evidence Into Action What we have learned about the potential risk of diabetes associated with COVID-19 could have important clinical and public health implications.
  Journal of Clinical Endocrinology & Metabolism, December 14, 2022
• Maternal PCOS and Pubertal Development in Daughters and Sons This study investigated whether maternal polycystic ovarian syndrome affects the timing of pubertal development in offspring.
  Human Reproduction, December 01, 2022
• Topical, Oral, Physical and Combined Treatments for Acne This meta-analysis examined current evidence on a wide range of treatments for acne vulgaris. Which are best for treatment of mild-to-moderate and moderate-to-severe acne?
  The British Journal of Dermatology, November 21, 2022
• N-acetyl-GED-0507-34-LEVO Gel in Moderate-to Severe Facial Acne This study demonstrates the the effectiveness and safety of a novel topical therapeutic agent for acne vulgaris which targets the nuclear receptor, PPARy, involved in sebum production.
  The British Journal of Dermatology, November 04, 2022
• Dermatologic Disease in Service Members and Mental Health This article explores the relationship between common dermatoses, reduced satisfaction with cutaneous body image, and increased risk for mental illness, self-harm, and suicide in military personnel.
  Cutis, October 19, 2022
• Direct-to-Consumer Teledermatology Growth This paper explores the recent and rapid expansion of direct-to-consumer teledermatology services. What are the risks and benefits of these platforms?
  Cutis, October 05, 2022